Approximately 15% of couples are affected by infertility and up to half of these cases arise from male factor infertility. Unidentified genetic aberrations such as chromosomal deletions, translocations and single nucleotide polymorphisms (SNPs) may be the underlying cause of many cases of idiopathic male infertility. Choline dehydrogenase (CHDH), a mitochondrial enzyme, catalyzes the conversion of choline to betaine, a methyl group donor and organic osmolyte. Deletion of the Chdh gene in mice results in decreased male fertility due to diminished sperm motility; sperm from Chdh−/− males have decreased ATP concentrations likely stemming from abnormal sperm mitochondrial morphology and function in these cells. SNPs have been identified in the human CHDH gene that may result in altered CHDH enzymatic activity. rs12676 (G233T), a non‐synonymous SNP located in the CHDH coding region, is associated with increased susceptibility to dietary choline deficiency and risk of breast cancer. We now report evidence that this SNP is also associated with altered sperm motility patterns and dysmorphic mitochondrial structure in sperm. Sperm produced by men who are GT or TT for rs12676 have 40% and 73% lower ATP concentrations, respectively, in their sperm. rs12676 is associated with decreased CHDH protein in human hepatocytes. We hypothesize that nutritional intervention involving dietary betaine supplementation may improve the function of sperm produced by men with the rs12676 SNP. This research was funded by NIH grants DK055865 and DK056350.Grant Funding Source: National Institutes of Health
Read full abstract